DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS

Aim:The purpose of this study, to evaluate digoxin toxicity and risk factors leading to digoxin toxicity in patients with therapeutic digoxin levels.Material and Methods: We studied ninety–five patients with digoxin level was above of the 1.4 ng/mL and below of the 2.0 ng/mL at admission. They were...

Full description

Bibliographic Details
Main Authors: Ugur Arslantas, Sinan Yildirim, Mehtap Bayram, Aynur Yurtseven, Tolga Cimen, Mehmet Dogan, Ekrem Yeter
Format: Article
Language:English
Published: Mustafa Kemal University 2015-09-01
Series:Mustafa Kemal Üniversitesi Tıp Dergisi
Subjects:
Online Access:http://dergipark.gov.tr/mkutfd/issue/19602/209484?publisher=mku
_version_ 1797918689429815296
author Ugur Arslantas
Sinan Yildirim
Mehtap Bayram
Aynur Yurtseven
Tolga Cimen
Mehmet Dogan
Ekrem Yeter
author_facet Ugur Arslantas
Sinan Yildirim
Mehtap Bayram
Aynur Yurtseven
Tolga Cimen
Mehmet Dogan
Ekrem Yeter
author_sort Ugur Arslantas
collection DOAJ
description Aim:The purpose of this study, to evaluate digoxin toxicity and risk factors leading to digoxin toxicity in patients with therapeutic digoxin levels.Material and Methods: We studied ninety–five patients with digoxin level was above of the 1.4 ng/mL and below of the 2.0 ng/mL at admission. They were divided into two groups, drug toxicity or nontoxicity, on the basis of both clinical symptoms and electrocardiography recording. The clinical and laboratory data were compared between these groups.Results: When overall patients’ digoxin usage indications were evaluated, it was revealed that 56 patients (58.9%) had been received digoxin only for heart failure, 32 patients (33.6%) only for atrial fibrillation and 20 patients (21%) received digoxin for both conditions. The exact reason for digoxin usage could not be determined in 17 patients (17.9%). When patients were evaluated, no differences in age, gender, medical history other than coronary artery disease and laboratory findings were observed between toxic and nontoxic patients. The medical history of coronary artery disease in toxic patients was significantly higher than in nontoxic patients (p: 0.008). In these variable, no differences were observed except atrial fibrillation (p<0.001), between toxic and nontoxic patients.Conclusion: In this study, the exact reasons for digoxin use could not be determined in 17 (17.9%) patients. In appropriate usage of digoxin could be increased risk of adverse outcomes and education program may reduce in appropriate use. Clinicians should be aware that signs of toxicity may occur at levels below of the 2.0 ng/mL, and such toxicity is more likely in the presence of atrial fibrillation or coronary artery disease.Keywords: Digoxin, toxicity, intoxication, serum digoxin levels
first_indexed 2024-04-10T13:33:33Z
format Article
id doaj.art-6c3ba166f07749719cf5da6778a5b26f
institution Directory Open Access Journal
issn 2149-3103
language English
last_indexed 2024-04-10T13:33:33Z
publishDate 2015-09-01
publisher Mustafa Kemal University
record_format Article
series Mustafa Kemal Üniversitesi Tıp Dergisi
spelling doaj.art-6c3ba166f07749719cf5da6778a5b26f2023-02-15T16:11:29ZengMustafa Kemal UniversityMustafa Kemal Üniversitesi Tıp Dergisi2149-31032015-09-01623212610.17944/mkutfd.10244102DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELSUgur ArslantasSinan YildirimMehtap BayramAynur YurtsevenTolga CimenMehmet DoganEkrem YeterAim:The purpose of this study, to evaluate digoxin toxicity and risk factors leading to digoxin toxicity in patients with therapeutic digoxin levels.Material and Methods: We studied ninety–five patients with digoxin level was above of the 1.4 ng/mL and below of the 2.0 ng/mL at admission. They were divided into two groups, drug toxicity or nontoxicity, on the basis of both clinical symptoms and electrocardiography recording. The clinical and laboratory data were compared between these groups.Results: When overall patients’ digoxin usage indications were evaluated, it was revealed that 56 patients (58.9%) had been received digoxin only for heart failure, 32 patients (33.6%) only for atrial fibrillation and 20 patients (21%) received digoxin for both conditions. The exact reason for digoxin usage could not be determined in 17 patients (17.9%). When patients were evaluated, no differences in age, gender, medical history other than coronary artery disease and laboratory findings were observed between toxic and nontoxic patients. The medical history of coronary artery disease in toxic patients was significantly higher than in nontoxic patients (p: 0.008). In these variable, no differences were observed except atrial fibrillation (p<0.001), between toxic and nontoxic patients.Conclusion: In this study, the exact reasons for digoxin use could not be determined in 17 (17.9%) patients. In appropriate usage of digoxin could be increased risk of adverse outcomes and education program may reduce in appropriate use. Clinicians should be aware that signs of toxicity may occur at levels below of the 2.0 ng/mL, and such toxicity is more likely in the presence of atrial fibrillation or coronary artery disease.Keywords: Digoxin, toxicity, intoxication, serum digoxin levelshttp://dergipark.gov.tr/mkutfd/issue/19602/209484?publisher=mku-Digoxin toxicity intoxication serum digoxin levelsDigoksin toksisite intoksikasyon serum digoksin düzeyleri
spellingShingle Ugur Arslantas
Sinan Yildirim
Mehtap Bayram
Aynur Yurtseven
Tolga Cimen
Mehmet Dogan
Ekrem Yeter
DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS
Mustafa Kemal Üniversitesi Tıp Dergisi
-
Digoxin
toxicity
intoxication
serum digoxin levels
Digoksin
toksisite
intoksikasyon
serum digoksin düzeyleri
title DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS
title_full DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS
title_fullStr DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS
title_full_unstemmed DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS
title_short DIGOXIN TOXICITY IN THERAPEUTIC SERUM LEVELS
title_sort digoxin toxicity in therapeutic serum levels
topic -
Digoxin
toxicity
intoxication
serum digoxin levels
Digoksin
toksisite
intoksikasyon
serum digoksin düzeyleri
url http://dergipark.gov.tr/mkutfd/issue/19602/209484?publisher=mku
work_keys_str_mv AT ugurarslantas digoxintoxicityintherapeuticserumlevels
AT sinanyildirim digoxintoxicityintherapeuticserumlevels
AT mehtapbayram digoxintoxicityintherapeuticserumlevels
AT aynuryurtseven digoxintoxicityintherapeuticserumlevels
AT tolgacimen digoxintoxicityintherapeuticserumlevels
AT mehmetdogan digoxintoxicityintherapeuticserumlevels
AT ekremyeter digoxintoxicityintherapeuticserumlevels